As of 05 Nov 2026 03:32 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2023/088 (21 Sep 2023): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Department of Health and Social Care (DHSC)affected product · inferred from phrasing | Discontinued, as stated | — not stated for this line | notice of 21 Sep 2023 |
| Lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devicesaffected product · inferred from phrasing | Discontinued, as stated | — not stated for this line | notice of 21 Sep 2023 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
The latest recorded notice names no alternative as remaining available.
Identifiers — Lixisenatide
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Sep 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 21 Sep 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 21 Sep 2023 | Medicine Supply Notification: Discontinuation of lixisenatide (Lyxumia® ) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices | Supply notification | Tier 2 | MSN/2023/088 |
Also recorded under
Bracketed names seen in this medicine's notice titles: lyxumia. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2023)26 Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for · issued 29 Sep 2023 · valid until stock will be exhausted by w/c 18th December 2023, as stated · matched by name PDF ↗